NCT03509584 2023-06-15
Phase I Multicenter Trial Combining Nivolumab, Ipilimumab and Hypo-fractionated Radiotherapy for Pretreated Advanced Stage Non-small Cell Lung Cancer Patients
Assistance Publique Hopitaux De Marseille
Phase 1 Terminated
Assistance Publique Hopitaux De Marseille
University of Texas Southwestern Medical Center